Status:

UNKNOWN

The CAVA Multicentre Dizziness Trial

Lead Sponsor:

Norfolk and Norwich University Hospitals NHS Foundation Trust

Collaborating Sponsors:

University Hospitals, Leicester

St George's University Hospitals NHS Foundation Trust

Conditions:

Ménière's Disease

Vestibular Migraine

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The CAVA trial is a diagnostic accuracy multicentre device trial which aims to quantify the extent to which the CAVA system can differentiate three common inner-ear causes of dizziness: Ménière's dise...

Detailed Description

This is a multicentre diagnostic accuracy study with a recruitment target of 255 adult participants. Recruitment will take place across ten sites in the UK, over two years. To be eligible, participant...

Eligibility Criteria

Inclusion

  • Age 18 and over
  • Must have relevant index medical condition: Ménière's Disease, Vestibular Migraine, posterior canal Benign Paroxysmal Positional Vertigo (see section 6.3.1.2 for specific criteria)
  • Experiencing episodes of true vertigo with at least 2 episodes within the preceding 4 weeks at time of consent
  • The duration and nature of the vertigo is of a duration and a nature supportive of the relevant index medical condition
  • Owns and able to use a telephone
  • Willing to provide informed consent
  • Willing to comply with the study protocol for using the CAVA device
  • Willing to complete all study materials
  • Adequate grasp of the English language or language used within an existing translated version of the informed consent form and patient information sheet and where hospital translators are available to provide support

Exclusion

  • Has an allergy to plasters and/or medical adhesives
  • Evidence of dermatitis, fragile skin, or any other condition that could be aggravated by the repeated application of skin surface adhesives
  • Pregnant or breastfeeding mothers
  • Bilateral or second side Ménière's Disease
  • Active bilateral or second side posterior canal Benign Paroxysmal Positional Vertigo
  • Currently enrolled on an intervention trial (not including questionnaire-based or observational trial)
  • Patients who meet diagnostic criteria for more than one eligible condition at time of recruitment

Key Trial Info

Start Date :

April 1 2022

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

March 31 2025

Estimated Enrollment :

255 Patients enrolled

Trial Details

Trial ID

NCT05984901

Start Date

April 1 2022

End Date

March 31 2025

Last Update

August 9 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Norfolk and Norwich University Hospitals Foundation Trust

Norwich, Norfolk, United Kingdom, NR4 7UY